2026 · 2nd Quarter (Apr 1 - June 30)

BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.)

Filed by BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.).

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: Not reported
Expenses: $350,000.00
Registrant: BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.)
Client: BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.)
Filing UUID: 1bd2e7bc-14a2-4ea4-9174-cefc28c83050
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to drug pricing, including federal proposals impacting reimbursement, access, and affordability; Issues related to Medicare Drug negotiation and implementation of the Inflation Reduction Act; Pharmacy benefit manager reform legislation; Issues related to Executive Order 14297- Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients; Issues related to Most Favored Nation (MFN) pricing models

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.